These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 1874188

  • 1. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
    Moon LY, Wakley GK, Turner RT.
    Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
    [Abstract] [Full Text] [Related]

  • 2. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
    Firling CE, Evans GL, Wakley GK, Sibonga J, Turner RT.
    J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone.
    Sibonga JD, Bell NH, Turner RT.
    J Bone Miner Res; 1998 May; 13(5):863-70. PubMed ID: 9610751
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
    Cui L, Wu T, Liu YY, Deng YF, Ai CM, Chen HQ.
    Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
    [Abstract] [Full Text] [Related]

  • 8. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ, Chen HK, Qi H, Pirie CM, Simmons HA, Ma YF, Jee WS, Thompson DD.
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK, Ke HZ, Jee WS, Ma YF, Pirie CM, Simmons HA, Thompson DD.
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [Abstract] [Full Text] [Related]

  • 12. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L, Härkönen P, Väänänen K, Peng Z.
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats.
    Turner RT, Wakley GK, Hannon KS, Bell NH.
    J Bone Miner Res; 1987 Oct; 2(5):449-56. PubMed ID: 3455628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats.
    Gallagher A, Chambers TJ, Tobias JH.
    Endocrinology; 1993 Dec; 133(6):2787-91. PubMed ID: 8243306
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.
    Sibonga JD, Lotinun S, Evans GL, Pribluda VS, Green SJ, Turner RT.
    Endocrinology; 2003 Mar; 144(3):785-92. PubMed ID: 12586754
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Specific bone-protective effects of metabolites/derivatives of tamoxifen and clomiphene in ovariectomized rats.
    Ruenitz PC, Shen Y, Li M, Liang H, Whitehead RD, Pun S, Wronski TJ.
    Bone; 1998 Dec; 23(6):537-42. PubMed ID: 9855462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.